Search results
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 3 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 4 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...
Opinion: The one reason America’s population isn’t about to start shrinking | CNN
CNN.com· 5 days agoLast week, President Joe Biden committed a diplomatic faux pas when he chided India and Japan, two...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 4 days agoNovavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to...
Eltek Sets Earnings Release Date and Conference Call to Report First Quarter 2024 Results on May 21,...
FOX 23 News Albany· 14 hours agoPETACH-TIKVA, Israel, May 13, 2024 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, ...
Firm value adjustment speed through financial friction in the presence of earnings management and...
Nature· 3 days agoThe study examined data on nonfinancial sector firms in emerging economies, focusing specifically on representative countries from the Asia Pacific region, namely, China, India</ ...
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Digital Journal· 6 days agoSHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral ...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Digital Journal· 4 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...